CIK 0001833214 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SAB Biotherapeutics, Inc.
Sign in to watch- Ticker
- SABS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853899721
- Phone
- 305-845-2813
- Business address
- 777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
- Former names
- Big Cypress Acquisition Corp.
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Insider Changes in Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 3 Insider Initial Statement of Ownership
Page 8 of 22 · 433 filings